An Open Study of Tipepidine Hibenzate in Patients With Attention Deficit Hyperactivity Disorder (ADHD)
Not Applicable
- Conditions
- Attention Deficit / Hyperactivity Disorder (AD/HD)
- Registration Number
- JPRN-UMIN000024423
- Lead Sponsor
- Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with a previous hypersensitivity to Tipepidine Hibenzate. 2.Patients treated with typical antipsychotics and selective norepinephrine reuptake inhibitor (NRI) except atomoxetine and stimulants except methylphenidate. 3.Pregnant or breast-feeding women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ADHD Rating Scale-IV (ADHD-RS) Japanese Version [ Time Frame: Changes from baseline in ADHD-RS at 4-weeks ]
- Secondary Outcome Measures
Name Time Method Cognition using DN-CAS (Das-Naglieri Cognitive Assessment System) Japanese Version [ Time Frame: Change from baseline in the scores of battery at 4-weeks ]